154 related articles for article (PubMed ID: 19037991)
1. DNA methyltransferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells.
Qiu H; Yashiro M; Shinto O; Matsuzaki T; Hirakawa K
Cancer Sci; 2009 Jan; 100(1):181-8. PubMed ID: 19037991
[TBL] [Abstract][Full Text] [Related]
2. Synergic antiproliferative effect of DNA methyltransferase inhibitor in combination with anticancer drugs in gastric carcinoma.
Zhang X; Yashiro M; Ohira M; Ren J; Hirakawa K
Cancer Sci; 2006 Sep; 97(9):938-44. PubMed ID: 16805821
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of radiosensitivity by 5-Aza-CdR through activation of G2/M checkpoint response and apoptosis in osteosarcoma cells.
Li Y; Geng P; Jiang W; Wang Y; Yao J; Lin X; Liu J; Huang L; Su B; Chen H
Tumour Biol; 2014 May; 35(5):4831-9. PubMed ID: 24474250
[TBL] [Abstract][Full Text] [Related]
4. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine.
Karpf AR; Moore BC; Ririe TO; Jones DA
Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effect of 5-Aza-2'-deoxycytidine on human nasopharyngeal carcinoma xenograft in nude mice].
Zhang S; Kong WJ; Wang YJ; Han YC; Zhang D
Ai Zheng; 2005 Oct; 24(10):1201-5. PubMed ID: 16219133
[TBL] [Abstract][Full Text] [Related]
6. Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents.
Mirza S; Sharma G; Pandya P; Ralhan R
Mol Cell Biochem; 2010 Sep; 342(1-2):101-9. PubMed ID: 20455010
[TBL] [Abstract][Full Text] [Related]
7. Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells.
Tanaka T; Bai T; Toujima S; Utsunomiya T; Matsuoka T; Kobayashi A; Yamamoto M; Sasaki N; Tanizaki Y; Utsunomiya H; Tanaka J; Yukawa K
Oncol Rep; 2012 Apr; 27(4):1292-8. PubMed ID: 22246465
[TBL] [Abstract][Full Text] [Related]
8. Effect of 5-aza-2'-deoxycytidine on immune-associated proteins in exosomes from hepatoma.
Xiao WH; Sanren GW; Zhu JH; Li QW; Kang HR; Wang RL; Song LP; Ye M
World J Gastroenterol; 2010 May; 16(19):2371-7. PubMed ID: 20480522
[TBL] [Abstract][Full Text] [Related]
9. [Apoptosis and re-expression of p16 gene in the myeloma cell line U266 induced by synergy of histone deacetylase inhibitor and demethylating agent].
Du HL; Qi Y; Shi YJ; Bu DF; Wu SL
Ai Zheng; 2002 Oct; 21(10):1057-61. PubMed ID: 12508642
[TBL] [Abstract][Full Text] [Related]
10. Effects of 5-Aza-CdR on the proliferation of human breast cancer cell line MCF-7 and on the expression of Apaf-1 gene.
Xiong H; Qiu H; Zhuang L; Xiong H; Jiang R; Chen Y
J Huazhong Univ Sci Technolog Med Sci; 2009 Aug; 29(4):498-502. PubMed ID: 19662370
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
Bender CM; Pao MM; Jones PA
Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064
[TBL] [Abstract][Full Text] [Related]
12. Effects of 5-Aza-2'-deoxycytidine on expression of PP1γ in learning and memory.
Zhang Z; Yang J; Liu X; Jia X; Xu S; Gong K; Yan S; Zhang C; Shao G
Biomed Pharmacother; 2016 Dec; 84():277-283. PubMed ID: 27665473
[TBL] [Abstract][Full Text] [Related]
13. 5-Aza-2'-deoxycytidine induces cytotoxicity in BGC-823 cells via DNA methyltransferase 1 and 3a independent of p53 status.
Liu J; Zhang Y; Xie YS; Wang FL; Zhang LJ; Deng T; Luo HS
Oncol Rep; 2012 Aug; 28(2):545-52. PubMed ID: 22664909
[TBL] [Abstract][Full Text] [Related]
14. An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells.
Yashiro M; Qiu H; Hasegawa T; Zhang X; Matsuzaki T; Hirakawa K
Br J Cancer; 2011 Nov; 105(10):1522-32. PubMed ID: 21997136
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of 5-Aza-2'-deoxycytidine against gastric cancer involves DNA damage in an ATM-P53 dependent signaling pathway and demethylation of P16(INK4A).
Liu J; Xie YS; Wang FL; Zhang LJ; Zhang Y; Luo HS
Biomed Pharmacother; 2013 Feb; 67(1):78-87. PubMed ID: 23201008
[TBL] [Abstract][Full Text] [Related]
16. Combination effect of epigenetic regulation and ionizing radiation in colorectal cancer cells.
Kim JG; Bae JH; Kim JA; Heo K; Yang K; Yi JM
PLoS One; 2014; 9(8):e105405. PubMed ID: 25136811
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of activation of P53/P21 and demethylation of RUNX 3 in the cytotoxicity against Lovo cells induced by 5-Aza-2'-deoxycytidine.
Deng T; Zhang Y
Life Sci; 2009 Feb; 84(9-10):311-20. PubMed ID: 19159630
[TBL] [Abstract][Full Text] [Related]
18. HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells.
Chai G; Li L; Zhou W; Wu L; Zhao Y; Wang D; Lu S; Yu Y; Wang H; McNutt MA; Hu YG; Chen Y; Yang Y; Wu X; Otterson GA; Zhu WG
PLoS One; 2008 Jun; 3(6):e2445. PubMed ID: 18560576
[TBL] [Abstract][Full Text] [Related]
19. Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB.
Shen WJ; Dai DQ; Teng Y; Liu HB
World J Gastroenterol; 2008 Jan; 14(4):595-600. PubMed ID: 18203293
[TBL] [Abstract][Full Text] [Related]
20. 5-Aza-2'-deoxycytidine enhances maspin expression and inhibits proliferation, migration, and invasion of the bladder cancer T24 cell line.
Zhang H; Qi F; Cao Y; Zu X; Chen M; Li Z; Qi L
Cancer Biother Radiopharm; 2013 May; 28(4):343-50. PubMed ID: 23570371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
